Pharmacokinetics of Oligonucleotides and DNA
Oligonucleotides and therapeutic small interference RNA (siRNA) hold great promise as novel therapeutic agents designed to specifically and selectively inhibit ...
Chee-Onn Leong
Oligonucleotides as a New Therapeutic Class: Progress Report & Prescription
Paul Burke, PhD, Burke Bioventures LLC.
Oligonucleotide Therapeutics Society
Oligonucleotide purification with Tosoh Bioscience
With significant recent increases in oligonucleotide pipelines, Phu Duong, PhD, Product Manager, Process Media at Tosoh Bioscience LLC, explains the ...
Informa Connect Life Sciences
Antisense oligonucleotide therapy
Frank Rigo, PhD, Isis Pharmaceuticals, discusses Exon Skipping.
Oligonucleotide Therapeutics Society
Chemistry of Therapeutic Oligonucleotides: A Brief Overview
Muthiah Manoharan, PhD, Alnylam Pharmaceuticals discusses the chemistry of Therapeutic Oligionucleotides.
Oligonucleotide Therapeutics Society
Peptide Oligonucleotide Conjugates for use as Nanoscale Building Blocks
Josephine_Boesen_A4.
Josephine Boesen
Delivery of Macromolecular Therapeutics: Tackling a Billion Year Old Barrier
All macromolecular therapeutics, including ASOs, siRNAs, peptides, proteins, CRISPR, mRNA and non-viral DNA vectors, are taken up into cells by endocytosis.
Oligonucleotide Therapeutics Society
Webinar "Simplifying Oligonucleotide Drug Development Workflows with Mass Spectrometry"
There has been noteworthy progress in the oligonucleotide therapeutics field over the past 30 years, beginning with antisense oligonucleotides (ASOs) and ...
Bruker Daltonics
Oligonucleotide and mRNA therapeutics with Anna Collén, AstraZeneca
Anna Collén, Senior Project Director, Innovative Medicine at AstraZeneca, discusses the latest oligonucleotide work at AZ and the biggest challenges that still ...
Informa Connect Life Sciences
Informa's Oligonucleotides and Peptides Conference -- EuroTIDES & EuroPEPTIDES
Informa's EuroTIDES & EuroPEPTIDES are two meetings combined to offer one unique conference experience. As one major event it is dedicated to exploring ...
Informa Connect Life Sciences
MCSGP enabled HPLC for Peptide / Oligo /ADC /RNA purification
Triple yield at target purity while reducing buffer (solvent) consumption by up to 70% using a new GMP production scale HPLC system enabled with the patented ...
YMC Process Technologies - formerly LEWA PT
Anastasia Khvorova: RNAi-based Therapeutics: 2018 Outlook
A decade of progress in oligonucleotide chemistry and formulation development has resulted in several compounds, both siRNAs and antisense, demonstrating ...
Oligonucleotide Therapeutics Society
Overcoming oligonucleotide analysis challenges with Intertek
Dr Jo-Anne Riley, Senior Scientist, Oligonucleotide Services at Intertek Pharmaceutical Services, discusses the challenges involved with oligonucleotide ...
Informa Connect Life Sciences
Short course: Antibodies: Sequence, Structure and Designing Therapeutics
Dr Andrew Martin and Professor Kerry Chester collaborate on a 2-day short course that is open to all: Antibodies: Sequence, Structure and Designing ...
UCL Short Courses
Nonclinical Strategies for Oligonucleotide Development Programs
Jennifer Lockridge, PhD.
Oligonucleotide Therapeutics Society
Aptamers in Drug Development: From Biomarker Discovery to Targeted Drug Delivery..
Presented At: LabRoots - Drug Discovery Virtual Event 2019 Presented By: Bill Jackson, PhD - Founder and Chief Scientist, Base Pair Biotechnologies Speaker ...
LabRoots
Modified Aptamers as Replacement for Antibodies in Diagnostics and Therapeutics
Dr. Casey Woodward 8. Strategies for Active Targeting by Molecular Recognition CLINAM 2016 - day 1 Hall Singapore 27.6.16.
TAUVOD
Oligo Meeting 2017 - mRNA
Matthew Stanton, PhD, Moderna Therapeutics.
Oligonucleotide Therapeutics Society
Biochemistry Focus webinar series: A brief history of biopharmaceuticals
During this webinar, Siân Estdale, Head of Scientific Affairs at Covance Laboratories Limited, presents a brief historical context for large molecules, the current ...
Biochemical Society
Webinar - Bioanalysis by Hybridization ELISA for Antisense Oligonucleotides
How hybridization ELISA can be an effective approach to quantify antisense oligonucleotides in circulation and in their targeted tissue. - The advantages and ...
Altasciences
Inside the Lab - Insights Into Oligonucleotides
Inside the Lab is a space for you – the scientist, the researcher, the chromatographer – to ask any and all technical questions you might have! This episode ...
Phenomenex
Introduction
In the last two decades, an increasing fraction of pharmaceutical R&D has been devoted to biotechnology-derived drugs (biotech drugs) – large molecules such ...
Chee-Onn Leong
New antibodies and antibody-drug conjugates for B-cell lymphoma
Earn CME: https://naccme.com/program/7316 In this presentation from the 'Surviving and Thriving with B-Cell Malignancies: Surveying an Ever-Evolving ...
ImedexCME
50 Years of Phosphorothioate Nucleic Acids
Fritz Eckstein, PhD, Max Planck Institute of Experimental Medicine, disusses 50 years of Phosphorothioate Nucleic Acids.
Oligonucleotide Therapeutics Society
Producing Peptides Using Bacteria - An Alternative Approach
While chemically synthesized peptides are excellent tools, the in-house production of peptides using bacteria offers clear advantages and great flexibility ...
Integrated DNA Technologies
Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology
Web: http://benthamscience.com/journals/current-topics-in-medicinal-chemistry/article/132626/ Author: Dr. Cesare Gennari Current Topics in Medicinal ...
Bentham Science
Roland Knispel (ChemAxon): Biomolecules at ChemAxon
ChemAxon's Biomolecule Toolkit – now extended with an editor, called BioEddie - is a webservice-based toolkit to bridge the gap between biology and ...
ChemAxon
Carolyn Bertozzi - Dana-Farber Targeted Degradation Webinar Series
Prof. Carolyn Bertozzi - Targeted degradation of extracellular proteins https://bertozzigroup.stanford.edu/ About Dana-Farber Targeted Protein Degradation ...
Dana-Farber TPD
Arcturus Therapeutics' Pad Chivukula, CSO & COO, presents at the 2020 TIDES Conference
See Pad Chivukula, CSO & COO, at Arcturus Therapeutics present the Development of a self-transcribing and replicating (STARR™) mRNA vaccine candidate ...
Arcturus Therapeutics
siRNA and Gene Delivery with Novel Peptide Nanoparticles
Dr. Neil Desai, Ph.D, Aadigen, LLC, Pacific Palisades, California (USA) 19. Nucleic Acid Nanomedicine CLINAM 2017 Hall Singapore 9.5.17.
TAUVOD
Roland Knispel (ChemAxon): Biomolecule Toolkit
ChemAxon's Biomolecule Toolkit is a webservice-based toolkit to bridge the gap between biology and chemistry for complex biomolecular entities. It provides ...
ChemAxon
ArtScience Talks @ Le Lab – Seeing Is Believing: Therapeutic Cancer Vaccines
Wyss Core Faculty member David Mooney presents a talk with Mary Mooney, titled Seeing Is Believing: Therapeutic Cancer Vaccines. Marshalling a patient's ...
Harvard University
Nanomaterials for Cancer Diagnosis
Biomedical Nanotechnology
Thunder-Link® PLUS Webinar: A guide to Immuno-PCR
In this presentation we will discuss how immuno-PCR draws on the advantages of both ELISA and real-time PCR, will take you through the main steps of an ...
Expedeon
Structured Nucleic Acid Nanoparticle Therapeutic Delivery Platform
mitdeshpandecenter
High Throughput Antibody Screening Using Synthetic Libraries Coupled with Kinetic & Binning Assays
Rapidly screen synthetic antibody libraries to discover the next blockbuster therapeutic. When sorting through a heap of antibody candidates from a library, ...
Carterra
Lipid Nanoparticle Delivery Technology for siRNA and mRNA Therapeutics
Lipid Nanoparticle Delivery Technology for siRNA and mRNA Therapeutics - Kathryn Whitehead Education Session from the American Society of Gene & Cell ...
ASGCT
[Recorded Webinar] PROTAC — Developing New Therapies through Targeted Protein Degradation
This webinar is brought to you by Collaborative Drug Discovery, the provider of CDD Vault hosted informatics platform that allows secure and centralized data ...
Collaborative Drug Discovery, Inc.
Oligonucleotide Intact Mass Confirmation on the BioAccord System LC/MS System
Barbara Sullivan, Waters Biopharmaceutical Group Leader in the MS Applications Lab, gives an overview of the BioAccord System and demonstrates the ...
Waters Corporation
Understanding the Benefits of Polymertic HPLC Columns for Oligonucleotide Purification
Synthetic oligonucleotide purifications are demanding applications for HPLC columns. Methods are commonly performed at more than 100 degrees Celsius and ...
Hamilton Lab Products (Americas & Pacific)
Synthetic Antibodies The Emerging Field of Aptamers in Diagnostics and Drug Discovery
Presented At: LabRoots - Drug Discovery Virtual Event 2019 Presented By: G. Thomas Caltagirone, PhD - President & CEO, Aptagen, LLC Speaker Biography: ...
Aptagen
Antibody-Nanoparticle Conjugation Webinar: Gold nanoparticles - optimization of conjugates
In this webinar the CEO and CSO of Innova Biosciences, Dr Nick Gee, provides an in-depth overview of the properties of gold nanoparticles and approaches for ...
Expedeon
